Navigation Links
Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA
Date:10/5/2007

additional information

on precautionary measures.

-- In clinical trials, the most frequently reported adverse events

associated with APTIVUS/r were diarrhea, nausea, fever, vomiting,

fatigue, headache and abdominal pain.

Please see full Prescribing Information (PI), including boxed WARNINGS, for APTIVUS at http://www.APTIVUS.com. The PI is in the new Physicians Labeling Rule (PLR) format required by the U.S. FDA.

Additional Information about APTIVUS

APTIVUS, a non-peptidic protease inhibitor, works by inhibiting protease, an enzyme needed to complete the HIV replication process. The approved dose of APTIVUS is 500 mg taken with 200 mg of ritonavir, twice daily.

APTIVUS is also approved in Argentina, Australia, Canada, Switzerland, Mexico, Iceland, Taiwan and the European Union.

Boehringer Ingelheim is actively conducting a clinical trial program to further evaluate APTIVUS for the treatment of HIV-1 infection. The program is comprised of ongoing and planned studies in more than 1,000 HIV-infected patients.

About Boehringer Ingelheim

Boehringer Ingelheim is committed to improving HIV therapy by providing physicians and patients with innovative antiretroviral agents.

For more information on Boehringer Ingelheim Pharmaceuticals, Inc., please visit http://us.boehringer-ingelheim.com.

(1) Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, October 10, 2006; Treatment for Adult HIV Infection. 2006 Recommendations of the International AIDS Society - - USA Panel. JAMA. 296(7): 837. August 16, 2006.


'/>"/>
SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Allos Therapeutics PDX Granted Orphan Medicinal Product Designation by the European Commission
2. Pixantrone Granted Fast Track Designation by FDA for Relapsed Indolent NHL Patients
3. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 2014 /CNW/ - On Aug. 20, at its annual ... Medical Association (CMA) voted on and approved a delegate ... medicinal cannabis. Bedrocan Cannabis Corp., a leading Canadian licensed ... motion. The CMA is quite right to ... smoking any plant material, including medicinal cannabis. While some ...
(Date:8/22/2014)... 22, 2014 MC Medical, a subsidiary of Mitsubishi ... Columbus, OH medical device company, have formally ... and robotic visualization system in Japan . ... in Japan in the latter half ... an extensive product portfolio in endoscopic surgery market in ...
(Date:8/22/2014)... Aug. 22, 2014 Research and Markets ... and Chinese Particulate Respirators Industry Report 2014" report ... Chinese Particulate Respirators Industry Report 2014 is a professional ... global particulate respirators industry with a focus on the ... of the industry including definitions, classifications, applications and industry ...
Breaking Medicine Technology:Bedrocan Canada Statement Regarding Canadian Medical Association Motion on Smoking Marijuana 2MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Global and Chinese Particulate Respirators Industry Report 2014 2
... Oct. 21 Sanofi-aventis announced today,that the ... (MHLW) has granted,approval for a Supplemental New ... coronary syndrome (unstable angina pectoris, non-ST elevation,myocardial ... being planned" for Plavix(R) (clopidogrel). Approximately ...
... Makes Cover of ... Molecular Cell, BUFFALO, N.Y., ... the structure,of the first mammalian GRP94 protein implicated in immune diseases such ... a,cover article in a top scientific journal -- Molecular Cell. Gewirth,s ...
Cached Medicine Technology:Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned 2Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned 3Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned 4Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned 5First High-Res 3-D Structures of Mammalian HSP90 Protein Solved, Key to Better Targets for AIDS, Sepsis, Cancer Drugs 2First High-Res 3-D Structures of Mammalian HSP90 Protein Solved, Key to Better Targets for AIDS, Sepsis, Cancer Drugs 3First High-Res 3-D Structures of Mammalian HSP90 Protein Solved, Key to Better Targets for AIDS, Sepsis, Cancer Drugs 4
(Date:8/22/2014)... Millennium Treatment Group has recently noticed an ... level of drug use among teenagers. The treatment facility aims ... and work to minimize drug abuse. , America is currently ... addiction in history. According to the National Institute of ... aged 12 or older—or 9.2 percent of the population—had used ...
(Date:8/22/2014)... Amy Norton HealthDay Reporter ... growing number of Americans on work disability chronically use ... Researchers found that between 2007 and 2011, about 44 ... were prescribed narcotic painkillers each year. And the percentage ... 2007 to 23 percent in 2011. Experts ...
(Date:8/22/2014)... Many Americans know little about how Ebola is transmitted and ... the United States, a new survey shows. About four ... be a major Ebola outbreak in the United States, and ... will get sick with the deadly virus in the next ... poll. However, those opinions don,t match reality, the Harvard ...
(Date:8/22/2014)... NV (PRWEB) August 22, 2014 Natural ... Kevin Richardson to restore his own vision from legally blind ... Michaels, prompting an investigative review. , “There is a ... or contacts for everyday function, and most people just think ... to corrective eye surgery that can be pretty risky at ...
(Date:8/22/2014)... DENVER Bcl-2-like protein 11 (BIM) deletion in ... with shorter progression free survival (PFS) in epidermal ... or chemotherapy treated Asian patients. Also, BIM deletion ... patients. , The BIM protein can activate the ... pathway in cells. BIM deletion has been detected ...
Breaking Medicine News(10 mins):Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 4Health News:Many Americans Harbor Unfounded Fears About Ebola Outbreak: Survey 2Health News:Natural Clear Vision: Review Exposes Kevin Richardson’s Program for Restoring Vision Naturally 2Health News:Deletion predicts survival in advanced non-small cell lung cancer 2
... to new environments, scientists say , FRIDAY, Dec. 14 (HealthDay ... light on skin color changes in humans. , A ... gene that,s responsible for color differences in both species. , ... have little in common, they share many similarities, noted study ...
... Bowes Program Bolstered by Celebrity Support, WASHINGTON, ... grateful for supportive cards, especially during,the holiday season. ... to the,American Red Cross for delivery to hospitalized ... and his wife, Elizabeth, heard,about the program and ...
... Illinois smokers comply with new law, CHICAGO, Dec. 14 ... taking effect January 1. Smoke Free,Illinois makes it illegal to ... $250.00., Non-smokers are thrilled to get rid of those ... furious. Further forced into exile, smokers,can,t even huddle by the ...
... yoga one step further with,a personalized yoga mat. Introduced ... lovers the option to embroider their name, friend,s,name, or ... yoga mat., (Logo: http://www.newscom.com/cgi-bin/prnh/20071214/NYF023LOGO ), ... to offer more,options when choosing a yoga mat. "I ...
... and Lejon,Boudreaux are running a minimum of a marathon ... and tons of highway,debris to get a message across., ... to:, http://www.prnewswire.com/mnr/blackaidsinstitute/31094/ , "We want 1 million African ... National HIV Testing Day," says Sacco, 26, who came ...
... , FRIDAY, Dec. 14 (HealthDay News) -- Men whose mothers, ... in the BRCA1 or BRCA2 genes may also have the ... study finds. , Most of those men are unaware ... in Philadelphia, who examined how families discuss genetic test results. ...
Cached Medicine News:Health News:Fish Give Clues to Human Skin Color Changes 2Health News:Randy Travis Participates in American Red Cross Holiday Card Program to Wounded Service Members 2Health News:Randy Travis Participates in American Red Cross Holiday Card Program to Wounded Service Members 3Health News:Smoke Free Illinois is a Positive Change 2Health News:Is Your Yoga Mat Lacking Personality? 2Health News:Photo: Two Men Raising Awareness of HIV/AIDS by Running Minimum of a Marathon a Day from San Francisco to Los Angeles 2Health News:Photo: Two Men Raising Awareness of HIV/AIDS by Running Minimum of a Marathon a Day from San Francisco to Los Angeles 3Health News:Breast Cancer Genes Also Raise Men's Risk for Malignancy 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: